Latest health news from http://reuters.us.feedsportal.com/c/35217/f/654207/s/49c18f6b/sc/7/l/0L0Sreuters0N0Carticle0C20A150C0A90C110Cus0Emerck0Ecladribine0EidUSKCN0ARB0AHF20A150A9110DfeedType0FRSS0GfeedName0FhealthNews/story01.htm
Thursday, September 10, 2015
Merck KGaA tries to revive multiple sclerosis pill cladribine
FRANKFURT (Reuters) - Germany's Merck KGaA said it would submit its cladribine tablets to treat multiple sclerosis for registration in Europe, taking aim at a comeback for a drug it had given up on four years ago.
Latest health news from http://reuters.us.feedsportal.com/c/35217/f/654207/s/49c18f6b/sc/7/l/0L0Sreuters0N0Carticle0C20A150C0A90C110Cus0Emerck0Ecladribine0EidUSKCN0ARB0AHF20A150A9110DfeedType0FRSS0GfeedName0FhealthNews/story01.htm
Latest health news from http://reuters.us.feedsportal.com/c/35217/f/654207/s/49c18f6b/sc/7/l/0L0Sreuters0N0Carticle0C20A150C0A90C110Cus0Emerck0Ecladribine0EidUSKCN0ARB0AHF20A150A9110DfeedType0FRSS0GfeedName0FhealthNews/story01.htm
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment